Skip to nav Skip to content

Global Health

Facebook Twitter LinkedIn Email

IDSA prioritizes promoting sufficient US investment in global infectious diseases responses and research, and in using the voices of physician scientists to inform multilateral and national global health policies. IDSA is a trusted leader in shaping and advancing international and national policies and investments in global HIV, TB, health security and antimicrobial resistance.

 

IDSA Statement for 146th WHO Executive Board Meeting
February 2020
Item 15.2: Health Emergencies

Global Health Council supported by the Infectious Diseases Society of America commend WHO on its invaluable work in responding to health emergencies. The WHO plays an essential role in strengthening global capacity to respond to health threats and ensuring effective coordination among all actors during health emergencies.

IDSA Statement for 146th WHO Executive Board Meeting
February 2020
Item 10: Ending TB

Global Health Council supported by the Infectious Diseases Society of America and the Global Health Technologies Coalition commends WHO and member states on accelerating efforts to meet global TB elimination goals. Despite some progress the world is not on track to end the TB epidemic by 2030.

IDSA Statement for 146th WHO Executive Board Meeting
February 2020
Item 8: Global vaccine action plan

Global Health Council supported by the Infectious Diseases Society of America and the Global Health Technologies Coalition commend WHO and member states on progress made towards achieving global immunization targets.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.